CardioDynamics Planning CHF Study Of BioZ.Com Hemodynamic Monitor
This article was originally published in The Gray Sheet
A pivotal, multi-center study of CardioDynamics' BioZ.Com noninvasive hemodynamic monitor is anticipated to commence by year-end to evaluate its use in treating congestive heart failure.
You may also be interested in...
Prucka Engineering's suite of cardiac catheterization and electrophysiology equipment will complement GE Marquette Medical Systems' offerings in diagnostic cardiology following an acquisition announced by both companies Aug. 24.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.